Can Herpes Simplex Virus (HSV) cause Stevens-Johnson Syndrome (SJS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Herpes Simplex Virus as a Cause of Stevens-Johnson Syndrome

Yes, herpes simplex virus (HSV) can cause Stevens-Johnson Syndrome (SJS), particularly in children, and is recognized as an important infectious trigger of this severe mucocutaneous reaction. 1

Relationship Between HSV and SJS

Infectious Triggers of SJS

  • HSV is specifically identified in multiple guidelines as a known infectious trigger for SJS/TEN 1
  • While medications are the most common cause of SJS/TEN in adults, infections are more frequently implicated in children, with up to 50% of pediatric cases attributed to infectious causes 1
  • HSV joins Mycoplasma pneumoniae as one of the most frequently documented infectious causes of SJS 2, 3

Clinical Distinction

  • It's important to distinguish between:
    • Erythema multiforme major (EMM): Typically caused by HSV and predominantly affects the extremities with typical target lesions 1
    • SJS: More severe reaction with widespread purpuric macules or flat atypical targets and less than 10% body surface area (BSA) involvement 1
    • SJS/TEN overlap: 10-30% BSA involvement 1
    • TEN: Greater than 30% BSA involvement 1

Diagnostic Considerations

Clinical Features

  • SJS presents with:
    • Widespread purpuric macules or flat atypical targets
    • Mucosal involvement (often severe)
    • Epidermal detachment (<10% BSA in SJS)
    • Prodromal symptoms including fever, malaise, and respiratory symptoms 1

Histopathology

  • Skin biopsy shows:
    • Variable epidermal damage ranging from individual cell apoptosis to confluent epidermal necrosis
    • Basal cell vacuolar degeneration
    • Subepidermal vesicle or bulla formation
    • Mild perivascular infiltrate of lymphocytes and histiocytes 1

Testing for HSV

  • When HSV is suspected as a trigger:
    • PCR testing of vesicular fluid
    • Serological testing for HSV antibodies
    • Testing for other potential infectious triggers (particularly M. pneumoniae) should be performed concurrently 1

Management of HSV-Associated SJS

Immediate Actions

  • Prompt recognition and early intervention are critical 2
  • Discontinue any potential triggering medications 1
  • Initiate antiviral therapy (acyclovir) when HSV is identified or strongly suspected 4, 5

Treatment Approach

  • Supportive care remains the cornerstone of management:
    • Specialized care in appropriate units (burn centers or intensive care units for severe cases)
    • Wound care and prevention of secondary infections
    • Fluid and electrolyte management
    • Nutritional support
    • Ophthalmological care for ocular involvement 1, 2

Prevention of Recurrence

  • HSV-associated SJS has been documented to recur in some patients 4, 5
  • Prophylactic strategies for patients with recurrent HSV-associated SJS include:
    • Continuous low-dose acyclovir prophylaxis
    • Early intervention with higher-dose acyclovir and prednisone at the first sign of HSV reactivation 4, 5, 6
    • This approach has been shown to successfully prevent progression to SJS in patients with recurrent disease 5

Special Considerations in Children

  • SJS recurrence is more common in children (up to 18% of cases) 2
  • Children with HSV-associated SJS should be managed in age-appropriate specialist units 1
  • Prophylactic antiviral therapy may be considered in children with recurrent HSV-associated SJS 2

Prognosis and Complications

  • Mortality rates vary: 1-5% for SJS, 25-35% for TEN 3
  • Long-term sequelae may include:
    • Skin pigmentation changes
    • Scarring
    • Ocular complications
    • Respiratory and urogenital problems 2, 3

HSV-associated SJS requires prompt recognition, immediate treatment with antivirals when indicated, and comprehensive supportive care to minimize morbidity and mortality. For patients with recurrent HSV-associated SJS, prophylactic strategies should be strongly considered to prevent future episodes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Facial Skin Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Orphanet journal of rare diseases, 2010

Research

Virus induced erythema multiforme and Stevens-Johnson syndrome.

Allergy proceedings : the official journal of regional and state allergy societies, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.